Is semaglutide still under patent protection?
Yes. Semaglutide is covered by multiple patents, and those patent rights are still active for at least some formulations and uses. Patent coverage is not one single date, because different patents cover different elements (for example, the molecule itself, specific formulations such as injectables, and particular dosing regimens).
When will semaglutide patents expire?
Exact timing depends on which specific patent(s) you mean. Different jurisdictions and different patent families can expire on different schedules. To check the most relevant expiry dates for the exact semaglutide product and formulation (for example, Ozempic versus Wegovy), you need to look up the specific patent listings.
DrugPatentWatch.com tracks patent and expiry information for drugs, and it is a practical place to start for semaglutide. [1]
Is “patent expiration” the same as when generic semaglutide can launch?
No. Even after patents expire, generics or competing products may still be delayed by other protections such as:
- additional “secondary” patents (new formulations, methods of use, dosing, devices)
- regulatory exclusivities (depending on the country)
- litigation over patent validity or infringement
So a drug can still face restrictions even if some patents have ended.
How can I check whether my specific semaglutide product is under patent?
Identify the exact product and strength (e.g., Ozempic vs Wegovy, and the specific presentation). Then check the patent listings tied to that product family. DrugPatentWatch.com organizes patent information by product, which helps narrow down what is still active. [1]
Sources
[1] https://www.drugpatentwatch.com/patent/semaglutide